GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » EBIT per Share

Halberd (Halberd) EBIT per Share : $ (TTM As of Jul. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Halberd EBIT per Share?

Halberd's EBIT per Share for the six months ended in Jul. 2023 was $-0.00. Halberd does not have enough years/quarters to calculate its EBIT per Share for the trailing twelve months (TTM) ended in Jul. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Halberd's EBIT per Share or its related term are showing as below:

HALB's 3-Year EBIT Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 3.4
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Halberd's EBIT for the six months ended in Jul. 2023 was $-0.45 Mil.


Halberd EBIT per Share Historical Data

The historical data trend for Halberd's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd EBIT per Share Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
EBIT per Share
- - -

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
EBIT per Share - - -

Halberd EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Halberd's EBIT per Share for the fiscal year that ended in Jul. 2023 is calculated as

EBIT per Share(A: Jul. 2023 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.447/537.108
=-0.00

Halberd's EBIT per Share for the quarter that ended in Jul. 2023 is calculated as

EBIT per Share(Q: Jul. 2023 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.447/537.108
=-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Halberd  (OTCPK:HALB) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


Halberd EBIT per Share Related Terms

Thank you for viewing the detailed overview of Halberd's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Halberd (Halberd) Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 25, Jackson Center, PA, USA, 16133
Halberd Corp is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases. The Company's patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing.
Executives
John Christopher Maddox director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO 10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist director, 10 percent owner, officer: CEO, Secretary and Director 24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr. director 50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas director 280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236